LRN STRIDE INC
Real Estate · Russell 2000
Next earnings: Tue 26 Jan 2027 · estimated
What 7 analyst firms say about STRIDE INC: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
6 rated views · 8 analyst/firm records · 7 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Fewer than 4 price targets in the last 6 months (3)
- Russell 2000 · Safest consensus · 6MNot scored · Fewer than 4 price targets in the last 6 months (3)
Recent analyst activity · last 90 days
Our tracked history has 4 reports on LRN from 4 analyst firms in the last 90 days (7 firms in the past year).
Comparing each firm's latest target with its previous one: 1 lowered it and 1 left it unchanged.
Ratings, latest available report against the previous one: 1 upgrade and 0 downgrades.
Latest observed target change: Barrington Research lowered its target from $125.00 (set 16 Apr 2026) to $115.00 on 23 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Barrington Research | Alexander Paris | Buy | 23 Oct 2026 | 115.00 USD |
| BMO Capital Markets | Andrew Bauch | Hold | 5 Oct 2026 | 90.00 USD |
| BMO Capital Markets | Jeffrey M Silber | Hold | 31 Jul 2026 | 90.00 USD |
| Canaccord Genuity | Jason Tilchen | Buy | 28 Jan 2026 | 125.00 USD |
| Morgan Stanley | Greg Parrish | Hold | 17 Dec 2025 | 95.00 USD |
| Weiss Ratings | Unnamed analyst | — | 16 Oct 2026 | — |
| William Blair | Stephen Sheldon | ConflictConflicting reports · excluded | 30 Jul 2026 | — |
| Data feed RESEARCH | Research Team | Buy | 28 Oct 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 02:45 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.